JESSICA MIGLIN: Open Payments
NPI 1528214285 · WALDWICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$402 in 18 payments from 6 companies in 2025. Trend: 2023 $57 · 2024 $285 · 2025 $402
Food & beverage: $402
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $139 |
| Alkermes, Inc. | 7 | $122 |
| E.R. Squibb & Sons, L.L.C. | 4 | $65 |
| ABBVIE INC. | 2 | $32 |
| Janssen Pharmaceuticals, Inc | 2 | $31 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
Products named: REXULTI, ARISTADA, COBENFY, LYBALVI, VRAYLAR, INVEGA SUSTENNA, UZEDY.
Industry payments across NJ — which companies pay providers there.
